# Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility

> **NCT05792813** · EARLY_PHASE1 · UNKNOWN · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 162 (estimated)

## Conditions studied

- Male Infertility
- Asthenozoospermia
- Oligoasthenozoospermia

## Interventions

- **DRUG:** LGYY
- **DRUG:** LGYY mimetic
- **DRUG:** WZYZ
- **DRUG:** WZYZ mimetic

## Key facts

- **NCT ID:** NCT05792813
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06
- **Primary completion:** 2024-06
- **Final completion:** 2024-12
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2023-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05792813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05792813, "Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05792813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*